Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 6,021–6,040 of 17,964 drug recalls

Drug Recall Terminated Historical recordClass III

Nystatin Oral Suspension, USP 500,000 units/5mL Cup, Delivers 5 mL, Rx Only, Manufactured by: VistaPharm, Largo, FL 33771, a) NDC 66689-037-50 (individual cup NDC: 66689-037-01); b) 66689-037-99.

by VistaPharm, Inc.

Reason
Failed impurities/degradation products; Presence of an impurity peak that exceeds the approved specification.
Recall initiated
June 23, 2020
Reported by FDA
July 15, 2020
Distribution
United States including Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass III

Brimonidine Tartrate Opthalmic Solution 0.2%, 15 mL bottle, Rx only, Manufactured for: Somerset Therapeutics, LLC Hollywood, FL 33024. Made in India. NDC 70069-233-01

by SOMERSET THERAPEUTICS LLC

Reason
Failed Impurities/Degradation Specification: There is a slow leaching process from the product label on the bottle which may impact the product over the shelf life.
Recall initiated
June 4, 2020
Reported by FDA
July 15, 2020
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass III

Brimonidine Tartrate Opthalmic Solution 0.2%, 10 mL bottle, Rx only, Manufactured for: Somerset Therapeutics, LLC Hollywood, FL 33024. Made in India. NDC 70069-232-01

by SOMERSET THERAPEUTICS LLC

Reason
Failed Impurities/Degradation Specification: There is a slow leaching process from the product label on the bottle which may impact the product over the shelf life.
Recall initiated
June 4, 2020
Reported by FDA
July 15, 2020
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass III

Brimonidine Tartrate Opthalmic Solution 0.2%, 5 mL bottle, Rx only, Manufactured for: Somerset Therapeutics, LLC Hollywood, FL 33024. Made in India. NDC 70069-231-01

by SOMERSET THERAPEUTICS LLC

Reason
Failed Impurities/Degradation Specification: There is a slow leaching process from the product label on the bottle which may impact the product over the shelf life.
Recall initiated
June 4, 2020
Reported by FDA
July 15, 2020
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass III

Zilretta (triamcinolone acetonide extended-release injectable suspension), 32mg per vial, 5mL vials, Single-dose Kits, Rx Only, Manufactured for: Flexion Therapeutics, Inc. 10 Mall Road, Suite 301, Burlington, MA 01803, NDC 70801-003-01

by Flexion Therapeutics, Inc.

Reason
Temperature Abuse: Product was stored at room temperature longer than 6 weeks and was inadvertently distributed instead of discarded
Recall initiated
May 19, 2020
Reported by FDA
July 8, 2020
Distribution
Nationwide within the United States only lots distributed by Besse Medical are affected.

View recall →

Drug Recall Terminated Historical recordClass II

Metformin HCl Extended Release Tablets, USP, 500 mg, Generic for Glucophage XR, Pkg Size 100, Mfg: Time-Cap, Labs Inc., Farmingdale, NY, Preferred Pharmaceuticals, Anaheim, CA NDC: 68788-6932-01

by Preferred Pharmaceuticals, Inc.

Reason
CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.
Recall initiated
June 17, 2020
Reported by FDA
July 8, 2020
Distribution
Product was distributed to two medical clinics located in FL.

View recall →

Drug Recall Terminated Historical recordClass I

Minoxidil/Biotin/Spironolactone 1.25/5/25 mg capsule, 90 capsules per bottle, This is a compounded drug not for resale, Store at room temperature, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419.

by MasterPharm LLC

Reason
Super-potent Drug: This recall has been initiated due to the elevated presence of minoxidil and biotin.
Recall initiated
June 9, 2020
Reported by FDA
July 8, 2020
Distribution
FL and MD

View recall →

Drug Recall Terminated Historical recordClass II

Childrens Dimetapp Cold & Cough, For ages 6 yrs. & over, 8 FL OZ. bottle, (237 mL), Distributed by: Pfizer Madison, NJ 07940, Made in Canada, UPC: 60300312234196, NDC: 0031-2234-19.

by Glaxosmithkline Consumer Healthcare Holdings

Reason
Defective Delivery System: the dosing cups are missing graduations applicable to certain age groups.
Recall initiated
June 16, 2020
Reported by FDA
July 8, 2020
Distribution
Nationwide in the US

View recall →

Drug Recall Terminated Historical recordClass II

Childrens Robitussin Honey Cough and Chest Congestion DM, dextromethorphan (cough suppressant), guaifenesin (expectorant), 4 FL OZ. bottle (118 mL), Distributed by: Pfizer, Madison, NJ 07940 USA, UPC: 50300318760128, NDC: 0031-8760-12.

by Glaxosmithkline Consumer Healthcare Holdings

Reason
Defective Delivery System: the dosing cups are missing graduations applicable to certain age groups.
Recall initiated
June 16, 2020
Reported by FDA
July 8, 2020
Distribution
Nationwide in the US

View recall →

Drug Recall Terminated Historical recordClass II

Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg, 100 Tablets (10 x 10) unit dose cartons, Rx only, Manufactured by: Apotex, Inc., Toronto, Ontario, Canada, Manufactured for: Apotex Corp. Weston, FL, Distributed by: Major Pharmaceuticals, Livonia, MI 48152 NDC 00904-5794-61

by The Harvard Drug Group

Reason
CGMP Deviation: Potential presence of Nitrosodimethylamine (NDMA) Impurity above the established levels.
Recall initiated
June 12, 2020
Reported by FDA
July 8, 2020
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

Koala Hand Sanitizer, Unscented, 16 FL OZ., Antibacterial, (Ethyl Alcohol 70%), Manufactured by Beaming White LLC, 1205 NE 95th St., Vancouver, WA 98665

by Beaming White Llc

Reason
Subpotent Drug: active ingredient ethanol tested below label claim and there is presence of undeclared isopropyl alcohol.
Recall initiated
June 12, 2020
Reported by FDA
July 8, 2020
Distribution
Nationwide within the United States

View recall →

Drug Recall Terminated Historical recordClass II

Koala Hand Sanitizer, Menthol, 16 FL OZ., Antibacterial, (Ethyl Alcohol 69%), Manufactured by Beaming White LLC, 1205 NE 95th St., Vancouver, WA 98665

by Beaming White Llc

Reason
Subpotent Drug: active ingredient ethanol tested below label claim and there is presence of undeclared isopropyl alcohol.
Recall initiated
June 12, 2020
Reported by FDA
July 8, 2020
Distribution
Nationwide within the United States

View recall →

Drug Recall Terminated Historical recordClass II

Koala Hand Sanitizer, Soothing Eucalyptus, 16 FL OZ., Antibacterial, (Ethyl Alcohol 68%), Manufactured by Beaming White LLC, 1205 NE 95th St., Vancouver, WA 98665

by Beaming White Llc

Reason
Subpotent Drug: active ingredient ethanol tested below label claim and there is presence of undeclared isopropyl alcohol.
Recall initiated
June 12, 2020
Reported by FDA
July 8, 2020
Distribution
Nationwide within the United States

View recall →

Drug Recall Ongoing Historical recordClass II

amneal Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg, 90 count bottle, Rx Only, Distributed by: Amneal Pharmaceuticals LLC Bridgewater, NJ 08807 NDC 53746-0178-90

by Amneal Pharmaceuticals of New York, LLC

Reason
CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level
Recall initiated
May 29, 2020
Reported by FDA
July 1, 2020
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass III

Nabumetone Tablets, USP, 500 mg, 100 Tablets per carton (10 tablets x 10 blister cards), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC carton: 60687-374-01, NDC unit dose: 60687-374-11

by American Health Packaging

Reason
Labeling Not Elsewhere Classified: The statement Pharmacist: Dispense with the accompanying Medication Guide was not included on the carton label.
Recall initiated
June 10, 2020
Reported by FDA
July 1, 2020
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

Clozapine Tablets USP tablet, 100mg, 500-count bottle, Rx only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520, Made in India, NDC 65862-846-05

by Aurobindo Pharma USA Inc.

Reason
Presence of foreign tablet: Consumer complaint of Clozapine Tablets 50mg being present in 500 count bottles of Clozapine Tablets USP 100mg.
Recall initiated
June 12, 2020
Reported by FDA
July 1, 2020
Distribution
U.S.A. Nationwide

View recall →

Drug Recall Terminated Historical recordClass III

Timolol Maleate Sterile Opthalmic Solution,USP 0.25%, 5 mL, Rx Only, For Topical Application, Distributed by: Rising Pharmaceuticals, Inc. Saddle Brook, NJ 07863, Manufactured by: FDC Limited B-8, MDC Industrial Area, Waluj, Aurangabad - 431-136 Maharashtra, India, NDC 64980-513-05

by Rising Pharmaceuticals, Inc.

Reason
Labeling: Label mix-up: A case of Timolol Maleate Sterile Ophthalmic solution USP 0.25%, 5ml, had the outer carton for Timolol Maleate Sterile Ophthalmic solution USP 0.5%, 5ml but the bottle inside was Timolol Maleate Sterile Ophthalmic solution USP 0.25%, 5ml.
Recall initiated
November 15, 2019
Reported by FDA
July 1, 2020
Distribution
U.S.A. Nationwide

View recall →

Drug Recall Terminated Historical recordClass III

Timolol Maleate USP, 0.5%, 5 mL, Sterile Opthalmic Solution, Rx Only, For Topical Application in the Eye, Distributed by: Rising Pharmaceuticals, Inc. Saddle Brook, NJ 07663, Manufactured by: FDC Limited B-8, MIDC Industrial Area, Waluj, Aurangbad - 431 136 Marahastra, India, NDC 64980-514-05

by Rising Pharmaceuticals, Inc.

Reason
Labeling: Label mix-up: A case of Timolol Maleate Sterile Ophthalmic solution USP 0.25%, 5ml, had the outer carton for Timolol Maleate Sterile Ophthalmic solution USP 0.5%, 5ml but the bottle inside was Timolol Maleate Sterile Ophthalmic solution USP 0.25%, 5ml.
Recall initiated
November 15, 2019
Reported by FDA
July 1, 2020
Distribution
U.S.A. Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Time-Cap Labs, Inc. Metformin Hydrochloride Extended-Release Tablets, USP 500 mg Rx Only 100 Tablets bottles, Manufactured for: Time-Cap Labs, Inc. 7 Michael Avenue Farmingdale, NY 11735, USA Manufactured by: Marksans Pharma Ltd. Plot No, L-82, L-83, Verna Intl. Estate, Verna, Goa-403 722, India NDC 49483-623-01

by Marksans Pharma Limited

Reason
CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level
Recall initiated
June 5, 2020
Reported by FDA
July 1, 2020
Distribution
Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

amneal Metformin Hydrochloride Extended-Release Tablets, USP, Bulk, Rx Only, Distributed by: Amneal Pharmaceuticals LLC Bridgewater, NJ 08807 NDC 53746-0179-BULK

by Amneal Pharmaceuticals of New York, LLC

Reason
CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level
Recall initiated
May 29, 2020
Reported by FDA
July 1, 2020
Distribution
Nationwide

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.